6710B ROCKLEDGE DRIVE
BETHESDA MD 20817
Dr. Long joined NICHD in 2017. She is board certified in obstetrics and gynecology and serves as the medical officer and project officer for the Contraceptive Clinical Trials Network. Previously, she served as medical officer in the Sexually Transmitted Diseases Branch at the National Institute of Allergy and Infectious Diseases (2012–2017) and performed premarket clinical review for obstetric/gynecologic devices at the U.S. Food and Drug Administration (2009-2012).
Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment.
Long JE(1), Wierzbicki MR, Hook EW 3rd.
Sex Transm Dis. 2017 Jun;44(6):362-364. doi: 10.1097/OLQ.0000000000000604.
Designing drug trials: considerations for pregnant women.
Sheffield JS(1), Siegel D(2), Mirochnick M(3), Heine RP(4), Nguyen C(5), Bergman KL(6), Savic RM(7), Long J(8), Dooley KE(9), Nesin M(8).
Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S437-44. doi: 10.1093/cid/ciu709.
Minimally invasive endometrial ablation device complications and use outside of the manufacturers' instructions.
Brown J(1), Blank K.
Obstet Gynecol. 2012 Oct;120(4):865-70.
Simulation training and resident performance of singleton vaginal breech delivery.
Deering S(1), Brown J, Hodor J, Satin AJ.
Obstet Gynecol. 2006 Jan;107(1):86-9.
Vulvar cancer in human immunodeficiency virus-seropositive premenopausal women: a case series and review of the literature.
Brown JE(1), Sunborg MJ, Kost E, Cosin JA, Winter WE 3rd.
J Low Genit Tract Dis. 2005 Jan;9(1):7-10.